About Indian Immunologicals
Indian Immunologicals is a company based in Hyderabad (India) founded in 1982. Indian Immunologicals offers products and services including Animal Vaccines, Human Vaccines, and Hepatitis A Vaccine. Indian Immunologicals operates in a competitive market with competitors including Biological E, Vir Biotechnology, Vaxcyte, Cidara Therapeutics and Freeline, among others.
- Headquarter Hyderabad, India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Indian Immunologicals Limited
- Date of Incorporation 08 Oct, 1999
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$99.76 M (USD)9.74as on Mar 31, 2022
-
Net Profit
$20.95 M (USD)246.88as on Mar 31, 2022
-
EBITDA
$31.79 M (USD)166.57as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Indian Immunologicals
Indian Immunologicals offers a comprehensive portfolio of products and services, including Animal Vaccines, Human Vaccines, and Hepatitis A Vaccine.
Vaccines designed to protect animals from diseases and promote health.
Vaccines for human preventive care against various illnesses.
First indigenously developed vaccine for hepatitis A prevention.
People of Indian Immunologicals
Unlock access to complete
Funding Insights of Indian Immunologicals
Detailed funding history for Indian Immunologicals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Indian Immunologicals
Investment portfolio details for Indian Immunologicals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Indian Immunologicals
Detailed financials for Indian Immunologicals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Indian Immunologicals Comparisons
Peer comparison for Indian Immunologicals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Indian Immunologicals
Indian Immunologicals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological E, Vir Biotechnology, Vaxcyte, Cidara Therapeutics and Freeline, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vaccines and therapeutics for multiple diseases are developed and marketed.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for the treatment of infectious diseases
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases are developed using cell-free protein synthesis.
|
|
| Locked | Locked | Locked |
Novel anti-infectives for bacterial and fungal infections are developed.
|
|
| Locked | Locked | Locked |
Gene therapy platform is developed for chronic disease treatments.
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases and solid tumors are developed.
|
Detailed competitors of Indian Immunologicals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Indian Immunologicals
Complete news archive for Indian Immunologicals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Indian Immunologicals
Indian Immunologicals was founded in 1982.
Indian Immunologicals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Annual revenue of Indian Immunologicals is $99.76M as on Mar 31, 2022.
The company was founded in 1982 in Hyderabad, India, and operates within the healthcare sector. Vaccines for both animal and human applications are developed and produced through dedicated research and development efforts. Novel products are created to address specific needs in health applications. Manufacturing processes are maintained to ensure consistent quality and delivery of these products.
Indian Immunologicals's top competitors include Vaxcyte, Serum Institute of India and Biological E.
Indian Immunologicals offers Animal Vaccines, Human Vaccines, and Hepatitis A Vaccine.